VKH
CLSD

Virtu KCG Holdings’s Clearside Biomedical CLSD Stock Holding History

Virtu KCG Holdings’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$166K Buy
+1,216
New +$146K ﹤0.01% 2246

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Virtu KCG Holdings's CLSD Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Clearside Biomedical (CLSD) in Q2 2017: 1,216 shares worth $166K. The stake represents ﹤0.01% of the portfolio and ranks #2246 among its holdings.

53 funds tracked by Wall St. Rank hold CLSD as of Q2 2017.

  • Virtu KCG Holdings held 1,216 shares of Clearside Biomedical worth $166K as of Q2 2017.
  • Clearside Biomedical was a new Virtu KCG Holdings position in Q2 2017.
  • Clearside Biomedical made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2246 holding.
  • 53 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.